UACI Alumni Reglagene Advances Brain Cancer Treatment
UACI startup alumni Reglagene is making impressive strides in brain cancer treatment research.
Based on research from the University of Arizona and launched through Tech Launch Arizona, Reglagene is gaining recognition for its brain-penetrant therapy, RGN6024. Recent highlights include:
✨ Featured as the cover story and “first disclosure” highlight in Molecular Cancer Therapeutics, a journal by the American Association for Cancer Research.
✨ Recognized as Molecule of the Month by Drug Hunter, a leading resource for drug discovery innovators.
We’re proud of the Reglagene team and look forward to their continued success! ?